Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

Renowned Diabetes Researcher Moves from Upmc to Allegheny Health Network Trucco, Researchers to Focus on Genetics and Immunology

Newspaper article Pittsburgh Post-Gazette (Pittsburgh, PA)

Renowned Diabetes Researcher Moves from Upmc to Allegheny Health Network Trucco, Researchers to Focus on Genetics and Immunology

Article excerpt

In February, Massimo Trucco said the fate of his decadeslong research to cure type 1 diabetes depended on a $7 million to $10 million grant from the National Institutes of Health.

Without funding, he said, he would shelve the research and retire.

Something unexpected has happened in the meantime.

The internationally renowned researcher currently based at Children's Hospital of Pittsburgh of UPMC, along with 19 members of his research team, are moving to the Allegheny Health Network, effective July 1.

Dr. Trucco, a professor of pediatric immunology with the University of Pittsburgh School of Medicine, will lead AHN's newly established Institute of Cellular Therapeutics, based at Allegheny General Hospital on the North Side. There his research will focus on genetics and immunology, with continuation of breakthrough diabetes research that's scheduled to undergo Phase II human clinical trials.

Other notable researchers following Dr. Trucco to AGH include Alejandro Soto-Gutierrez, Rita Bottino, Yong Fan and Nick Giannoukakis.

"Massimo Trucco is widely respected and recognized around the world for leading studies that have provided critical new information about the pathogenesis of type 1 diabetes and have pushed us ever closer to a cure for the highly prevalent and deadly disease," said Tony Farah, AHN's chief medical officer. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.